|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/4745 | |
| A61K 31/513 | |||
| A61K 31/519 | |||
| A61K 45/06 | |||
| A61P 35/00 | |||
| A61K 9/00 | |||
| A61K 9/127 | |||
| A61P 1/18 | |||
| A61P 9/00 | |||
| A61P 43/00 |
| (11) | Number of the document | 3266456 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17169098.5 |
| Date of filing the European patent application | 2013-06-12 | |
| (97) | Date of publication of the European application | 2018-01-10 |
| (45) | Date of publication and mention of the grant of the patent | 2021-05-05 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 201261659211 P | 2012-06-13 | US | |
| 201361784382 P | 2013-03-14 | US |
| (72) |
BAYEVER, Eliel, US
DHINDSA, Navreet, US
FITZGERALD, Jonathan, Basil, US
LAIVINS, Peter, US
MOYO, Victor, US
NIYIKIZA, Clet, US
KIM, Jaeyeon, US
|
| (73) |
Ipsen Biopharm Ltd.,
Ash Road, Wrexham Industrial Estate Wrexham LL13 9UF,
GB
|
| (54) | COMBINATIONS OF LIPOSOMAL IRINOTECAN, 5-FU AND LEUCOVORIN FOR THE TREATMENT OF PANCREATIC CANCER |
| COMBINATIONS OF LIPOSOMAL IRINOTECAN, 5-FU AND LEUCOVORIN FOR THE TREATMENT OF PANCREATIC CANCER |